BHVN Q1 2022 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$90M

Net Income

-$97M

EPS (Diluted)

$-2.71

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$59M

Free Cash Flow

-$59M

Stock-Based Comp.

$40M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$1.8B

Stockholders' Equity

$95M

Cash & Equivalents

-$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$44M	-100.0%
Gross Profit	$0	$31M	-100.0%
Operating Income	-$90M	-$236M	+61.9%
Net Income	-$97M	-$265M	+63.4%

Revenue Segments

Collaboration And Other

$195M61%

Product

$124M39%